CV SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0376 USD | -5.16% |
|
-5.28% | +6.50% |
| Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
| Mar. 28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the CV Sciences, Inc....
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +6.50% | 6.15M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- CVSI Stock
- News CV Sciences, Inc.
- Transcript : CV Sciences, Inc., Q3 2023 Earnings Call, Nov 14, 2023
